Pulmonx Corporation LUNG
2.83 USD +0.11 (+4.04%)
At closeNov 4, 2026, 7:58 PM EST
2.87 +0.04 +1.25%
After hours · Nov 4, 7:58 PM ET
2.77 Day range 3.01
1.13 52-week range 3.25
- YTD
- +28.05%
- 1 year
- +64.53%
Financial health
Altman Z-Score
-5.70 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 3
Valuation
P/E -1.7×
FY 2018 5y median -5.3× FY 2025
P/S 1.0×
FY 2018 5y median 5.8× FY 2025
P/B 1.7×
FY 2018 5y median 3.1× FY 2025
P/FCF -2.7×
FY 2018 5y median -8.1× FY 2025
EV/EBITDA -1.6×
FY 2018 5y median -4.9× FY 2025
EV/Sales 0.8×
FY 2018 5y median 4.4× FY 2025
FCF Yield -36.6%
FY 2018 5y median -12.4% FY 2025
Profitability
Gross Margin 74.2%
FY 2018 5y median 74.0% FY 2025
Operating Margin -59.3%
FY 2018 5y median -90.2% FY 2025
Net Margin -59.7%
FY 2018 5y median -88.6% FY 2025
ROE -99.8%
FY 2018 5y median -51.4% FY 2025
ROIC -48.5%
FY 2018 5y median -38.7% FY 2025
ROA -41.8%
FY 2018 5y median -34.2% FY 2025
Growth (YoY)
Revenue 8.0%
FY 2018 FY 2025
Operating Income 7.0%
FY 2018 FY 2025
EPS (diluted) 7.6%
FY 2018 FY 2025
Free Cash Flow 0.3%
FY 2018 FY 2025
Financial Health
Current Ratio 5.1×
FY 2018 5y median 6.5× FY 2025
Quick Ratio 4.3×
FY 2018 5y median 5.8× FY 2025
Debt / Equity 1.0×
FY 2018 5y median 0.4× FY 2025
Net Debt / EBITDA 0.3×
FY 2018 5y median 0.8× FY 2025
Interest Coverage -17.0×
FY 2018 5y median -19.2× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
